No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample

References 

1. Arcos-Burgos M, Muenke M. Genetics of population isolates. Clinical Genetics. 2002;61:233–247
   • MEDLINE
   • CrossRef
2. Del Zompo M, Ardau R, Palmas MA, Bocchetta A, Reina A, Piccardi MP. Lithium response: association study with two candidate genes. Molecular Psychiatry. 1999;4 (Suppl.):S66–S67
3. Dmitrzak-Weglarz M, Rybakowsky JK, Suwalska A, Stopień A, Czerski PM, Leszczynska-Rodziewicz A, et al. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacological Reports. 2005;57:761–765
4. Epstein MP, Satten GA. Inference on haplotype effects in case-control studies using unphased genotype data. American Journal of Human Genetics. 2003;73:1316–1329
   • MEDLINE
   • CrossRef
5. Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, Mac Dougall M, et al. Is response to prophylactic lithium a familial trait?. Journal of Clinical Psychiatry. 2002;63:942–947
6. Manchia M, Lampus S, Chillotti C, Sardu C, Ardau R, Severino G, et al. Age at onset in Sardinian bipolar I patients: evidence for three subgroups. Bipolar Disorders. 2008;10:443–446
   • CrossRef
7. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Archives of General Psychiatry. 1991;48:764–770
   • MEDLINE
8. Michelon L, Meira-Lima I, Cordeiro Q, Miguita K, Breen G, Collier D, et al. Association study of the INPP1, 5HTT, BDNF, AP-2β and GSK-3β gene variants and retrospectively scored response to lithium prophylaxis in bipolar disorder. Neuroscience Letters. 2006;403:288–293
   • MEDLINE
   • CrossRef
9. Post RM, Roy-Byrne PP, Uhde TW. Graphic representation of the life course of illness in patients with affective disorder. American Journal of Psychiatry. 1988;145:844–848
10. Rybakowsky JK, Suwalska A, Czerski PM, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacological Reports. 2005;57:124–127
11. Serretti A, Lilli R, Lorenzi C, Franchini L, Smeraldi E. Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders. International Journal of Neuropsychopharmacology. 1998;1:125–129
12. Serretti A, Lilli R, Lorenzi C, Franchini L, Di Bella D, Catalano M, et al. Dopamine receptor D2 and D4 genes, GABA alpha-1 A subunit genes and response to lithium prophylaxis in mood disorders. Psychiatry Research. 1999;87:7–19
    • Abstract
    • Full Text
    • Full-Text PDF (117 KB)
    • CrossRef
13. Serretti A, Lorenzi C, Lilli R, Smeraldi E. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders. Journal of Psychiatric Research. 2000;34:89–98
    • Abstract
    • Full Text
    • Full-Text PDF (139 KB)
    • CrossRef
14. Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. The Pharmacogenomics Journal. 2001;1:71–77
    • MEDLINE
    • CrossRef
15. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria for a Selected Group of Functional Disorders. 3rd ed.. New York: New York State Psychiatric Institute; 1977;